Bioxtend Neutraceutical Private Limited - Company Profile

It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2022.

2022 New Delhi, Delhi, India Active

Last Updated: February 21, 2026

About Bioxtend Neutraceutical Private Limited

Bioxtend Neutraceutical Private Limited, a active private limited company, was established on 16 June 2022 in New Delhi, Delhi, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299DL2022PTC400124. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.18 M.

Its leadership includes Pankaj Bansal (Additional Director), Chhavi Malhotra (Director). Past directors included Jagannathan Ragunathan. It is based at Shop B-1 Plot No. H-4 Right Portion Basement Floor Vardhman Northex Plaza, New Delhi, Delhi, 110034.

Company Details

CIN/LLPIN
U24299DL2022PTC400124
Registration Number
400124
Incorporation Date
16 June 2022
Authorized Capital
₹1.50 M
Paid-Up Capital
₹0.18 M
ROC Code
Roc Delhi Ii
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.50 M as on 21-02-2026
Paid Up Capital ₹ 0.18 M as on 21-02-2026
Company Age 3 Year, 8 Months

Comprehensive Company Insights

Explore comprehensive insights into Bioxtend Neutraceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Bioxtend Neutraceutical Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Pankaj Bansal	Additional Director	05 Apr 2023	Current
Chhavi Malhotra	Director	16 Jun 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	05 Apr 2023	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bioxtend Neutraceutical.

Enhance accessibility to Bioxtend Neutraceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bioxtend Neutraceutical?

Unlock access to Bioxtend Neutraceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bioxtend Neutraceutical?

Bioxtend Neutraceutical has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bioxtend Neutraceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioxtend Neutraceutical's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bioxtend Neutraceutical

Recent Activity within the Organization

Director Appointment

The activity Pankaj Bansal was appointed as a Additional Director was appointed as a Additional Director on 05 Apr 2023 & has been associated with this company since 2 years 10 months . was completed.
05 Apr 2023
Director Appointment

Progress on Chhavi Malhotra was appointed as a Director was appointed as a Director on 16 Jun 2022 & has been associated with this company since 3 years 8 months . was documented.
16 Jun 2022
Company Incorporation

Progress on Bioxtend Neutraceutical Private Limited was registered on 16 Jun 2022 with Roc Delhi Ii & aged 3 years 8 months as per MCA records. was documented.
16 Jun 2022

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Bioxtend Neutraceutical Private Limited?

The CIN of Bioxtend Neutraceutical Private Limited is U24299DL2022PTC400124.

Where is Bioxtend Neutraceutical Private Limited headquartered?

Bioxtend Neutraceutical Private Limited is headquartered at Shop B-1 Plot No. H-4 Right Portion Basement Floor Vardhman Northex Plaza, New Delhi, Delhi, 110034.

When was Bioxtend Neutraceutical Private Limited incorporated?

Bioxtend Neutraceutical Private Limited was incorporated on 16 June 2022.

Who are the current directors of Bioxtend Neutraceutical Private Limited?

The current directors of Bioxtend Neutraceutical Private Limited are

What is the primary industry of Bioxtend Neutraceutical Private Limited?

The primary industry of Bioxtend Neutraceutical Private Limited is Chemicals.

Is Bioxtend Neutraceutical Private Limited a listed company?

Bioxtend Neutraceutical Private Limited is unlisted.

What is the capital structure of Bioxtend Neutraceutical Private Limited?

The authorized capital of Bioxtend Neutraceutical Private Limited is ₹1.50 M, and the paid-up capital is ₹0.18 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available